Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: experimental design and artificial neural network optimization.
Galanthamine is a third-generation cholinesterase inhibitor used against Alzheimer's disease. New analytical methods for the determination of galanthamine in pharmaceutical preparatives and biological fluids, such as urine and serum, were developed. An experimental design and artificial neural network approach were used for method optimization. Thirty-five ppb of galanthamine were determined in serum samples (with addition of 10 mM magnesium chloride and using solid-phase preconcentration).
Pokorná
L
L
Masaryk University, Faculty of Science, Department of Analytical Chemistry, Brno, Czech Republic.
Revilla
A
A
Havel
J
J
Patocka
J
J
D000544:Alzheimer Disease / Q000188:drug therapy; D001826:Body Fluids / Q000737:chemistry*; D002800:Cholinesterase Inhibitors / Q000032:analysis*; D019075:Electrophoresis, Capillary / Q000379:methods*; D005702:Galantamine / Q000032:analysis* / Q000097:blood / Q000652:urine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016571:Neural Networks, Computer; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012044:Regression Analysis; D015203:Reproducibility of Results
D002800:Cholinesterase Inhibitors; D004364:Pharmaceutical Preparations; D005702:Galantamine